Dyne Therapeutics Inc (DYN)
Healthcare
Biotechnology
25.20 $
-2.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Dyne Therapeutics Inc (DYN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -130 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51 | -35 | -79 | -55 | -75 | -84 | -106 | -95 | -91 | -112 | -145 | -130 | -478 | |
| 0.4 | 0.6 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 2.1 | |
| 4.9 | 5.7 | 20 | 6.7 | 8.7 | 10 | 13 | 11 | 11 | 11 | 13 | 15 | 50 | |
| 4.5 | 26 | -33 | 4.2 | 14 | -5.1 | -3.6 | 5.6 | 5.9 | -11 | -38 | 33 | -10 | |
| 0.2 | 0.1 | 0.2 | 0.9 | 0.3 | 1.1 | 1.0 | 0.1 | 19 | 0.5 | 0.2 | 1.5 | 21 | |
| 13 | 26 | -180 | 11 | -19 | -16 | 1.5 | 6.8 | -38 | 1.0 | -2.4 | -4.8 | -44 | |
| – | – | – | – | – | – | 0.0 | 99 | 0.0 | 49 | 6.2 | 57 | 113 | |
| 0.5 | 0.1 | 408 | 380 | 18 | 3.6 | 141 | 101 | 217 | 431 | 7.1 | 58 | 713 | |
| -37 | -8.7 | 150 | 336 | -76 | -97 | 37 | 13 | 89 | 320 | -140 | -77 | 191 | |
| -51 | -35 | -79 | -56 | -75 | -85 | -107 | -95 | -110 | -112 | -145 | -132 | -499 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.